BELANOFF JOSEPH K 4
4 · CORCEPT THERAPEUTICS INC · Filed Jun 4, 2025
Insider Transaction Report
Form 4
BELANOFF JOSEPH K
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-06-02$80.30/sh−2,988$239,941→ 2,931,066 total(indirect: By Trust) - Sale
Common Stock
2025-06-02$79.48/sh−3,050$242,421→ 2,934,054 total(indirect: By Trust) - Sale
Common Stock
2025-06-02$84.57/sh−12,959$1,095,962→ 2,910,393 total(indirect: By Trust) - Sale
Common Stock
2025-06-02$78.42/sh−4,881$382,773→ 2,937,104 total(indirect: By Trust) - Sale
Common Stock
2025-06-02$85.01/sh−8,408$714,778→ 2,901,985 total(indirect: By Trust) - Sale
Common Stock
2025-06-02$82.26/sh−1,263$103,899→ 2,927,983 total(indirect: By Trust) - Sale
Common Stock
2025-06-02$83.46/sh−4,631$386,523→ 2,923,352 total(indirect: By Trust) - Sale
Common Stock
2025-06-02$81.33/sh−1,820$148,012→ 2,929,246 total(indirect: By Trust)
Footnotes (10)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction.
- [F10]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $85.00 to $85.31 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $77.84 to $78.83 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
- [F4]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $78.88 to $79.865 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F5]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $79.90 to $80.8925 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F6]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $80.92 to $81.78 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F7]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $81.935 to $82.80 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F8]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $82.96 to $83.95 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F9]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $83.975 to $84.94 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.